Izotropic Corporation (IZOZF)
USD 0.03
(-10.45%)
USD 0.03
(-10.45%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 2.05 Million CAD | -3.86% |
| 2023 | 2.13 Million CAD | 5.46% |
| 2022 | 2.02 Million CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | -100.0% |
| 2017 | 190.27 Thousand CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 2.06 Million CAD | -0.53% |
| 2024 Q4 | 2.05 Million CAD | -0.36% |
| 2024 FY | 2.05 Million CAD | -3.86% |
| 2024 Q2 | 2.07 Million CAD | -2.54% |
| 2024 Q1 | 2.12 Million CAD | -0.46% |
| 2023 Q1 | 2.02 Million CAD | 0.02% |
| 2023 Q3 | 2.13 Million CAD | 4.27% |
| 2023 Q2 | 2.04 Million CAD | 1.04% |
| 2023 FY | 2.13 Million CAD | 5.46% |
| 2023 Q4 | 2.13 Million CAD | 0.08% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q4 | 2.02 Million CAD | 0.0% |
| 2022 FY | 2.02 Million CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q3 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | -100.0% |
| 2018 Q1 | - CAD | -100.0% |
| 2017 FY | 190.27 Thousand CAD | 0.0% |
| 2017 Q4 | 190.27 Thousand CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 8.197% |
| Arrayit Corporation | 1.07 Million USD | -90.73% |
| Atlantic International Corp. | 2.93 Million USD | 29.828% |
| Biocept, Inc. | 12.1 Million USD | 83.018% |
| Bioqual, Inc. | 3.58 Million USD | 42.671% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -2731.947% |
| DermTech, Inc. | 54.39 Million USD | 96.219% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.564% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 57.459% |
| iMD Companies, Inc. | 1.12 Million USD | -83.582% |
| IDenta Corp. | 789.14 Thousand USD | -160.584% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 81.626% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -4590.136% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 74.439% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 46.251% |
| NovelStem International Corp. | 3.57 Million USD | 42.472% |
| Optigenex Inc. | 8.94 Million USD | 77.0% |
| PharmChem, Inc. | 77.35 Thousand USD | -2558.449% |
| Proteome Sciences plc | 17.15 Million USD | 88.012% |
| Response Genetics, Inc | 6.37 Million USD | 67.733% |
| Rennova Health, Inc. | 15.32 Million USD | 86.585% |
| RushNet, Inc. | 4.82 Million USD | 57.364% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -893.262% |
| Stella Diagnostics Inc. | 6.2 Million USD | 66.836% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -14.239% |
| Todos Medical Ltd. | 38.34 Million USD | 94.638% |